Natixis Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $297K | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $458K | Buy |
|
|||||
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $1.87M | Buy |
|
|||||
2022
Q4 | $1.48M | Buy |
|
|||||
2022
Q3 | $804K | Buy |
|
|||||
2022
Q2 | $890K | Sell |
|
|||||
2022
Q1 | $1.14M | Buy |
|
|||||
2021
Q4 | $1.18M | Buy |
|
|||||
2021
Q3 | $1.09M | Buy |
|
|||||
2021
Q2 | $996K | Buy |
|
|||||
2021
Q1 | $1M | Buy |
|
|||||
2020
Q4 | $893K | Buy |
|
|||||
2020
Q3 | $513K | Sell |
|
|||||
2020
Q2 | $3.84M | Sell |
|
|||||
2020
Q1 | $4.2M | Buy |
|
|||||
2019
Q4 | $4.17M | Buy |
|
|||||
2019
Q3 | $4.17M | Buy |
|
|||||
2019
Q2 | $3.75M | Sell |
|
|||||
2019
Q1 | $4.75M | Buy |
|
|||||
2018
Q4 | $3.08M | Buy |
|
|||||
2018
Q3 | $2.25M | Buy |
|
|||||
2018
Q2 | $2.04M | Sell |
|
|||||
2018
Q1 | $2.66M | Sell |
|
|||||
2017
Q4 | $2.35M | Sell |
|
|||||
2017
Q3 | $3.83M | Sell |
|
|||||
2017
Q2 | $4.34M | Buy |
|
|||||
2017
Q1 | $3.21M | Buy |
|
|||||
2016
Q4 | $1.19M | Sell |
|
|||||
2016
Q3 | $2.34M | Sell |
|
|||||
2016
Q2 | $4.79M | Buy |
|
|||||
2016
Q1 | $3.74M | Sell |
|
|||||
2015
Q4 | $4.92M | Sell |
|
|||||
2015
Q3 | $9.08M | Sell |
|
|||||
2015
Q2 | $8.39M | Sell |
|
|||||
2015
Q1 | $8.49M | Sell |
|
|||||
2014
Q4 | $7.59M | Buy |
|
|||||
2014
Q3 | $6.74M | Sell |
|
|||||
2014
Q2 | $12.5M | Buy |
|
|||||
2014
Q1 | $11.7M | Sell |
|
|||||
2013
Q4 | $12.5M | Buy |
|
|||||
2013
Q3 | $10.2M | Sell |
|
|||||
2013
Q2 | $9.52M | Buy |
|